News
Local
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate News
Hot Property
eNewspaper
________________
Subscriptions
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
Manage Subscription
EZPay
Delivery Issue
eNewspaper
Subscribe
Subscriber Terms
Gift Subscription Terms
About Us
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Contact us
Our Journalism Explained
Newsletters
Readers Rep
Careers
Events
Historical Archives
Podcasts and Livestreams
U-T Store
Events
Advertising
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Place an ad
Media kit
Rate book
Report an ad problem
Cars
Classifieds
Eldercare Directory
Jobs
Newspaper ad directory
Newspaper special sections
Real Estate
Sponsored
Stats Digital
Jobs
CaregiverSD
Community papers
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Del Mar Times
Encinitas Advocate
La Jolla Light
PB Monthly
Point Loma-OB Monthly
Pomerado News
Poway News Chieftain
Ramona Sentinel
Rancho Bernardo
Rancho Santa Fe Review
Games, Puzzles, and Crossword
Crossword
Sudoku
Crossword
Sudoku
Obituaries
Death Notices
Place an obituary
Death Notices
Place an obituary
U-T En Español
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Deportes
Comunidad
Espectáculos
Cierre de Edición, fotos, videos
Noticias
Privacy and Terms
Privacy
Terms
Advertising terms
Privacy
Terms
Advertising terms
Copyright © 2022, The San Diego Union-Tribune |
CA Notice of Collection
|
Do Not Sell My Personal Information
Sections
Sports
Business
Entertainment
Lifestyle
Opinion
Real Estate
Obituaries
eNewspaper
Newsletters
Show Search
Search Query
Submit Search
COVID-19
For subscribers
Phenomenal women
Latino life
Crossword
Sudoku
About Us
Contact us
Community Advisory Board
Readers Rep
Careers
Events
Historical Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Diego Stocks
San Diego Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Capricor Therapeutics, Inc. - Common Stock
(NQ:
CAPR
)
3.850
-0.340 (-8.11%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Capricor Therapeutics, Inc. - Common Stock
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
MarketBeat Week in Review – 9/30 - 10/4
October 05, 2024
A strong jobs report and a temporary settlement of the port strike lifted stocks but inflation and earnings data could set investors up for more volatility
Via
MarketBeat
Topics
Economy
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 04, 2024
Via
Benzinga
Apogee Enterprises Posts Upbeat Earnings, Joins Frontier Group, JetBlue Airways And Other Big Stocks Moving Higher On Friday
↗
October 04, 2024
Via
Benzinga
Nike Reports Weak Sales, Joins Lamb Weston And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
October 02, 2024
Via
Benzinga
Here's How Much $100 Invested In Capricor Therapeutics 5 Years Ago Would Be Worth Today
↗
September 30, 2024
Via
Benzinga
Deep Dive Into Capricor Therapeutics Stock: Analyst Perspectives (5 Ratings)
↗
September 20, 2024
Via
Benzinga
Unveiling 6 Analyst Insights On Capricor Therapeutics
↗
July 02, 2024
Via
Benzinga
IGM Biosciences, CPI Card And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
October 01, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 30, 2024
Via
Benzinga
Prime Medicine, MINISO Group, Li Auto, Weibo And Other Big Stocks Moving Higher On Monday
↗
September 30, 2024
Via
Benzinga
Capricor Therapeutics Is Up Over 100%, Could Rise Even Higher
September 30, 2024
Capricor Therapeutics Inc. (NASDAQ: CAPR) is a biotechnology firm focused on developing cell and exosome-based treatments for rare diseases like iomyopathy
Via
MarketBeat
What's Going On With Capricor Therapeutics Stock Friday?
↗
June 28, 2024
The biotechnology company said deramiocel increased cardiac function based on several different measures.
Via
Benzinga
Expert Ratings For Capricor Therapeutics
↗
May 14, 2024
Via
Benzinga
Recap: Capricor Therapeutics Q4 Earnings
↗
February 29, 2024
Via
Benzinga
Dow Tumbles Over 200 Points; CERo Therapeutics Shares Jump
↗
September 25, 2024
Via
Benzinga
Topics
Stocks
Crude Oil Down Over 1%; Stitch Fix Shares Plummet
↗
September 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
September 25, 2024
Via
Benzinga
Hewlett Packard Enterprise, Nvidia, Progress Software And Other Big Stocks Moving Higher On Wednesday
↗
September 25, 2024
Via
Benzinga
Nvidia, Alibaba, Capricor Therapeutics, TSMC, Tesla: Why These 5 Stocks Are On Investors' Radars Today
↗
September 24, 2024
On Tuesday, major U.S. indices closed higher, with the Dow Jones Industrial Average gaining 0.2% to reach 42,208.22.
Via
Benzinga
Topics
Stocks
Earnings Scheduled For February 29, 2024
↗
February 29, 2024
Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings at $0.46 per share on revenue of $276.19 million.
Via
Benzinga
Capricor Therapeutics's Earnings Outlook
↗
February 28, 2024
Via
Benzinga
Preview: Capricor Therapeutics's Earnings
↗
November 13, 2023
Via
Benzinga
Why Capricor Therapeutics Stock Is Soaring Tuesday
↗
September 24, 2024
Capricor Therapeutics Inc (NASDAQ:CAPR) shares are trading higher Tuesday after the company announced intent to file a biologics license application (BLA) for the full approval of Deramiocel for the...
Via
Benzinga
Week In Review: Nippon Shinyaku Signs $735 Million Deal For DMD Therapy
↗
September 21, 2024
Japan’s Nippon Shinyaku will acquire European rights for a Duchenne muscular dystrophy disease therapy developed by Capricor Therapeutics of San Diego. Nippon Shinyaku will pay $20 million upfront and...
Via
Talk Markets
EXCLUSIVE: Capricor Therapeutics Inks European Expansion, Commercialization Pact For Lead Asset With Japanese Pharma Firm
↗
September 17, 2024
Capricor Therapeutics partners with Nippon Shinyaku for the European commercialization of Duchenne muscular dystrophy treatment, deramiocel, with a potential $1.5 billion in milestone payments from...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
June 11, 2024
Via
Benzinga
What's Going On With Capricor Therapeutics Stock Tuesday?
↗
June 11, 2024
Capricor Therapeutics announced successful completion of a Type-B meeting with the U.S. Food and Drug Administration (FDA).
Via
Benzinga
What's Going On With Capricor Therapeutics Stock Tuesday?
↗
June 04, 2024
Capricor Therapeutics, Inc. (NASDAQ: CAPR) is trading higher Tuesday after the company announced three-year results from the ongoing HOPE-2 open-label extension
Via
Benzinga
CAPR Stock Earnings: Capricor Therapeutics Misses EPS, Misses Revenue for Q1 2024
↗
May 13, 2024
CAPR stock results show that Capricor Therapeutics missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
FlexShopper And 3 Other Penny Stocks Insiders Are Buying
↗
October 12, 2023
The Dow Jones closed higher by around 65 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
< Previous
1
2
...
7
8
9
10
11
12
13
14
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
